Operating Margin of Sarepta Therapeutics, Inc. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Sarepta Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • Sarepta Therapeutics, Inc. Operating Margin for the quarter ending 30 Sep 2025 was -5.2%, a 206% decline year-over-year.
  • Sarepta Therapeutics, Inc. annual Operating Margin for 2024 was 11%.
  • Sarepta Therapeutics, Inc. annual Operating Margin for 2023 was -22%, a 63% increase from 2022.
  • Sarepta Therapeutics, Inc. annual Operating Margin for 2022 was -57%, a 12% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Sarepta Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -5.2% -10% -206% 01 Jul 2025 30 Sep 2025
Q2 2025 -0.04% -2.6% -101% 01 Apr 2025 30 Jun 2025
Q1 2025 -5.2% +1.5% +22% 01 Jan 2025 31 Mar 2025
Q4 2024 11% +33% 01 Oct 2024 31 Dec 2024
Q3 2024 4.9% +41% 01 Jul 2024 30 Sep 2024
Q2 2024 2.5% +53% 01 Apr 2024 30 Jun 2024
Q1 2024 -6.8% +53% +89% 01 Jan 2024 31 Mar 2024
Q4 2023 -22% +36% +63% 01 Oct 2023 31 Dec 2023
Q3 2023 -36% +25% +41% 01 Jul 2023 30 Sep 2023
Q2 2023 -51% +1.7% +3.2% 01 Apr 2023 30 Jun 2023
Q1 2023 -60% -8.7% -17% 01 Jan 2023 31 Mar 2023
Q4 2022 -57% +8% +12% 01 Oct 2022 31 Dec 2022
Q3 2022 -61% +20% +25% 01 Jul 2022 30 Sep 2022
Q2 2022 -52% +52% +50% 01 Apr 2022 30 Jun 2022
Q1 2022 -52% +53% +51% 01 Jan 2022 31 Mar 2022
Q4 2021 -66% +39% +37% 01 Oct 2021 31 Dec 2021
Q3 2021 -81% +45% +35% 01 Jul 2021 30 Sep 2021
Q2 2021 -105% +31% +23% 01 Apr 2021 30 Jun 2021
Q1 2021 -104% +79% +43% 01 Jan 2021 31 Mar 2021
Q4 2020 -104% +81% +44% 01 Oct 2020 31 Dec 2020
Q3 2020 -126% +42% +25% 01 Jul 2020 30 Sep 2020
Q2 2020 -136% +27% +17% 01 Apr 2020 30 Jun 2020
Q1 2020 -183% -63% -52% 01 Jan 2020 31 Mar 2020
Q4 2019 -185% -71% -62% 01 Oct 2019 31 Dec 2019
Q3 2019 -168% -85% -103% 01 Jul 2019 30 Sep 2019
Q2 2019 -163% -79% -93% 01 Apr 2019 30 Jun 2019
Q1 2019 -120% -40% -50% 01 Jan 2019 31 Mar 2019
Q4 2018 -114% -3.1% -2.8% 01 Oct 2018 31 Dec 2018
Q3 2018 -83% +148% +64% 01 Jul 2018 30 Sep 2018
Q2 2018 -84% 01 Apr 2018 30 Jun 2018
Q1 2018 -80% 01 Jan 2018 31 Mar 2018
Q4 2017 -111% 01 Oct 2017 31 Dec 2017
Q3 2017 -231% 01 Jul 2017 30 Sep 2017

Sarepta Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 11% +33% 01 Jan 2024 31 Dec 2024
2023 -22% +36% +63% 01 Jan 2023 31 Dec 2023
2022 -57% +8% +12% 01 Jan 2022 31 Dec 2022
2021 -66% +39% +37% 01 Jan 2021 31 Dec 2021
2020 -104% +81% +44% 01 Jan 2020 31 Dec 2020
2019 -185% -71% -62% 01 Jan 2019 31 Dec 2019
2018 -114% -3.1% -2.8% 01 Jan 2018 31 Dec 2018
2017 -111% +4809% +98% 01 Jan 2017 31 Dec 2017
2016 -4920% +12652% +72% 01 Jan 2016 31 Dec 2016
2015 -17573% -16201% -1182% 01 Jan 2015 31 Dec 2015
2014 -1371% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.